Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVpc Specialty Regulatory News (VSL)

Share Price Information for Vpc Specialty (VSL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 48.20
Bid: 48.00
Ask: 49.30
Change: 0.00 (0.00%)
Spread: 1.30 (2.708%)
Open: 48.20
High: 0.00
Low: 0.00
Prev. Close: 48.20
VSL Live PriceLast checked at -
VPC Specialty Lending Investments is an Investment Trust

To generate an attractive total return for shareholders consisting of dividend income and capital growth through investments in specialty lending opportunities.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

VPC Impact Acquisition Holdings Sponsor III, LLC

7 Jun 2021 13:30

RNS Number : 0622B
VPC Specialty Lending Invest. PLC
07 June 2021
 

VPC Specialty Lending Investments PLC (the "Company")

 Update Regarding its Holding in VPC Impact Acquisition Holdings Sponsor III, LLC

 

The Company notes that earlier today, 7 June 2021, VPC Impact Acquisition Holdings III, Inc. (NYSE: VPCC) ("VPCC"), a special purpose acquisition company sponsored by VPC Impact Acquisition Holdings Sponsor III, LLC ("VPC Sponsor"), an affiliate of Victory Park Capital ("VPC"), announced it has entered into a definitive agreement to combine with Dave Inc. ("Dave") (https://www.dave.com/). For more information on the transaction please see the Dave and VPCC press release, which can be found here: https://www.victoryparkcapital.com/news/2021/06/07/dave-a-leading-banking-app-with-10-million-customers-announces-plans-to-become-publicly-traded-company-via-merger-with-vpc-impact-acquisition-holdings-iii-inc/. 

Through VPC Sponsor, VPC Specialty Lending Investments PLC ("VSL") currently owns 1,021,630 Class B Shares and 829,154 private placement warrants in VPCC, held at an aggregate cost basis of US$1,247,795. The transaction implies an approximately US$4 billion post-merger enterprise value at a US$10.00 price per Class A Common Stock. Upon the consummation of the transaction, 75% of VSL's Class B Shares shall be automatically converted into one share of Class A Common Stock of Dave with an aggregate undiscounted implied transaction value of US$7,662,230 to the Company representing a 1.6% increase to the 30 April 2021 NAV (before fees). The other 25% of VSL's Class B Shares have a vesting period of five years from the consummation of the transaction but are fully vested if the volume weighted average price ("VWAP") reaches defined levels for 20 out of 30 trading days at any time during this period. Of the remaining Class B Shares, 60% will vest at a VWAP of US$12.50 price per Class A Common Stock and the remaining 40% will vest at a VWAP of US$15.00 price per Class A Common Stock.

The Company will initially value the Class A Common Stock at the closing trade price and take a 30% discount to the value to take into account deal closing risk and illiquidity relating to the lock up on the Class A Common Stock. The discounted valuation above results in a value of US$5,363,561 representing a 1.0% increase to the 30 April 2021 NAV (before fees). There would be no value assigned to the remaining 25% of the Class B Shares until the shares have vested and convert into Class A Common Stock.

Similarly, each private placement warrant shall be converted into a warrant to purchase one share of Class A Common Stock of Dave. VSL holds 829,154 warrants, which maintain a US$11.50 per share strike price, provide for cashless exercise and expire five years after closing of the transaction. At a US$10.00 price per Class A Common Stock, there would be no value assigned to the private placement warrants as long as the Class A Common Stock traded price is below the strike price.

VSL's Class A Common Stock shall be subject to a one-year post-closing lockup unless otherwise accelerated based on average trading performance measured six months post-closing. The transaction is expected to close in the third quarter of 2021 and remains subject to VIH III shareholder approval amongst other closing conditions. 

The information contained in this announcement is inside information and is price sensitive.

 

Enquiries

 

For further information, please contact:

 

Victory Park Capital

Brendan Carroll (Senior Partner and Co-Founder)

Gordon Watson (Partner)

 

via Jefferies or Winterflood (below)

info@vpcspecialtylending.com

 

Jefferies International Limited

 

Tel: +44 20 7029 8000

Stuart Klein

Neil Winward

Gaudi le Roux

 

 

Winterflood Securities Limited

Tel: +44 20 3100 0000

Neil Morgan

Chris Mills

 

 

 

Link Company Matters Limited (Company Secretary)

 

Tel: +44 20 7954 9567

Email: VPC@linkgroup.co.uk

 

  

About VPC Specialty Lending Investments PLC

VPC Specialty Lending Investments PLC (Company No. 9385218) is a UK listed investment trust focused on asset-backed lending to emerging and established businesses with the goal of building long-term, sustainable income generation. The Company identifies investment opportunities across various industries and geographies to offer shareholders access to a diversified portfolio of opportunistic credit investments originated by non-bank lenders with a focus on the rapidly developing technology-enabled lending sector.

 

Further information on VPC Specialty Lending Investments PLC is available at: http://vpcspecialtylending.com.

 

LEI: 549300UPEXC5DQB81P34

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUBUURAKUNRAR
Date   Source Headline
2nd May 20244:27 pmRNSNotice of AGM
24th Apr 20247:00 amRNSAnnual Financial Report
22nd Apr 20247:00 amRNSNet Asset Value(s)
17th Apr 20244:30 pmRNSInitial Return of Capital Exchange Ratio
9th Apr 20247:00 amRNSInitial Return of Capital through B Share Scheme
5th Apr 202411:23 amRNSResult of General Meeting
15th Mar 20247:00 amRNSPublication of circular relating to B share scheme
8th Mar 20243:00 pmRNSNet Asset Value(s)
22nd Feb 20248:54 amRNSReplacement - Dividend Declaration
22nd Feb 20247:00 amRNSDividend Declaration
7th Feb 20249:00 amRNSNet Asset Value(s)
17th Jan 20247:00 amRNSNet Asset Value(s)
8th Dec 20237:00 amRNSNet Asset Value(s)
17th Nov 20237:00 amRNSDividend Declaration
13th Nov 20237:00 amRNSNet Asset Value and Monthly Report
5th Oct 20237:00 amRNSNet Asset Value and Monthly Report
29th Sep 20237:00 amRNSHalf-year Report
6th Sep 20237:00 amRNSNet Asset Value and Monthly Report
24th Aug 20237:00 amRNSDividend Declaration
8th Aug 20231:21 pmRNSNet Asset Value and Monthly Report
13th Jul 202311:45 amRNSNet Asset Value(s) and Monthly Report
26th Jun 20237:00 amRNSDividend Declaration
23rd Jun 20235:08 pmRNSResult of AGM
12th Jun 20235:31 pmRNSResult of Meeting
7th Jun 20237:00 amRNSNet Asset Value(s)
31st May 20231:26 pmRNSDirectorate Change and Notice of AGM
16th May 20232:58 pmRNSCircular containing a Notice of General Meeting
11th May 202310:07 amRNSNet Asset Value(s)
28th Apr 20237:00 amRNSAnnual Financial Report
11th Apr 20235:33 pmRNSHolding(s) in Company
6th Apr 20237:00 amRNSNet Asset Value(s)
7th Mar 20237:00 amRNSNet Asset Value(s)
22nd Feb 20237:00 amRNSDividend Declaration
10th Feb 20237:00 amRNSNet Asset Value(s)
12th Jan 20237:00 amRNSNet Asset Value(s)
22nd Dec 20227:00 amRNSProposed Managed Wind-Down
8th Dec 20227:00 amRNSNet Asset Value(s)
7th Dec 20224:01 pmRNSReceipt of Requisition Notice
30th Nov 20227:00 amRNSDividend Declaration
8th Nov 20227:00 amRNSNet Asset Value(s)
11th Oct 202211:13 amRNSHolding(s) in Company
30th Sep 20227:00 amRNSNet Asset Value(s)
29th Sep 20227:00 amRNSHalf-year Report
31st Aug 20227:00 amRNSNet Asset Value(s)
25th Aug 20227:00 amRNSDividend Declaration
1st Aug 20227:00 amRNSNet Asset Value(s)
30th Jun 20227:00 amRNSNet Asset Value(s)
14th Jun 20227:00 amRNSDividend Declaration
13th Jun 20224:35 pmRNSResult of AGM
8th Jun 20227:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.